1. Home
  2. TSBX vs MNDR Comparison

TSBX vs MNDR Comparison

Compare TSBX & MNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • MNDR
  • Stock Information
  • Founded
  • TSBX 2015
  • MNDR 2016
  • Country
  • TSBX United States
  • MNDR Singapore
  • Employees
  • TSBX N/A
  • MNDR N/A
  • Industry
  • TSBX
  • MNDR
  • Sector
  • TSBX
  • MNDR
  • Exchange
  • TSBX Nasdaq
  • MNDR Nasdaq
  • Market Cap
  • TSBX 11.2M
  • MNDR 9.3M
  • IPO Year
  • TSBX 2023
  • MNDR 2024
  • Fundamental
  • Price
  • TSBX $0.39
  • MNDR $0.50
  • Analyst Decision
  • TSBX Buy
  • MNDR
  • Analyst Count
  • TSBX 3
  • MNDR 0
  • Target Price
  • TSBX $4.75
  • MNDR N/A
  • AVG Volume (30 Days)
  • TSBX 345.8K
  • MNDR 24.5M
  • Earning Date
  • TSBX 03-20-2025
  • MNDR 10-29-2024
  • Dividend Yield
  • TSBX N/A
  • MNDR N/A
  • EPS Growth
  • TSBX N/A
  • MNDR N/A
  • EPS
  • TSBX N/A
  • MNDR N/A
  • Revenue
  • TSBX N/A
  • MNDR $13,968,535.00
  • Revenue This Year
  • TSBX N/A
  • MNDR $188,831.77
  • Revenue Next Year
  • TSBX N/A
  • MNDR $76.44
  • P/E Ratio
  • TSBX N/A
  • MNDR N/A
  • Revenue Growth
  • TSBX N/A
  • MNDR 77.38
  • 52 Week Low
  • TSBX $0.37
  • MNDR $0.23
  • 52 Week High
  • TSBX $5.75
  • MNDR $29.50
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 40.91
  • MNDR N/A
  • Support Level
  • TSBX $0.37
  • MNDR N/A
  • Resistance Level
  • TSBX $0.42
  • MNDR N/A
  • Average True Range (ATR)
  • TSBX 0.04
  • MNDR 0.00
  • MACD
  • TSBX -0.00
  • MNDR 0.00
  • Stochastic Oscillator
  • TSBX 16.62
  • MNDR 0.00

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.

Share on Social Networks: